相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MicroRNA-93-5p expression in tumor tissue and its tumor suppressor function via targeting programmed death ligand-1 in colorectal cancer
Yi-Lin Chen et al.
CELL BIOLOGY INTERNATIONAL (2020)
MicroRNA-93 targets WASF3 and functions as a metastasis suppressor in breast cancer
Naoki Shibuya et al.
CANCER SCIENCE (2020)
MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics
Elena Vila-Navarro et al.
ONCOGENESIS (2020)
miR-93-5p enhances migration and invasion by targeting RGMB in squamous cell carcinoma of the head and neck
Shuiting Zhang et al.
JOURNAL OF CANCER (2020)
Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance
Dai-Min Xiang et al.
GUT (2019)
Hepatic Resection Compared to Chemoembolization in Intermediate- to Advanced-Stage Hepatocellular Carcinoma: A Comment For Moving Forward
Dun-Chang Mo et al.
HEPATOLOGY (2019)
RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog
Junxia Cao et al.
THERANOSTICS (2019)
Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis
Lei Liang et al.
HPB (2018)
Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies
Nuozhou Wang et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Chronic Inflammation-Elicited Liver Progenitor Cell Conversion to Liver Cancer Stem Cell With Clinical Significance
Xiao-Feng Li et al.
HEPATOLOGY (2017)
Shp2 Promotes Liver Cancer Stem Cell Expansion by Augmenting β-Catenin Signaling and Predicts Chemotherapeutic Response of Patients
Daimin Xiang et al.
HEPATOLOGY (2017)
MicroRNA in breast cancer: The association with BRCA1/2
Nina Petrovic et al.
CANCER BIOMARKERS (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Crosstalk between Long Noncoding RNAs and MicroRNAs in Health and Disease
Ahmed S. Bayoumi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Liver cancer stem cell markers: Progression and therapeutic implications
Jing-Hui Sun et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients
Tao Han et al.
JOURNAL OF HEPATOLOGY (2015)
Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4
Liang Li et al.
GUT (2015)
Tumor heterogeneity and cancer stem cell paradigm: Updates in concept, controversies and clinical relevance
Anup Kumar Singh et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Surgery Versus Transarterial Chemoembolization for Solitary Large Hepatocellular Carcinoma of BCLC Stage A
Young-Joo Jin et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2014)
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Jeffrey A. Magee et al.
CANCER CELL (2012)
CD24+ Liver Tumor-Initiating Cells Drive Self-Renewal and Tumor Initiation through STAT3-Mediated NANOG Regulation
Terence Kin Wah Lee et al.
CELL STEM CELL (2011)
Mutational analysis of mononucleotide repeats in dual specificity tyrosine phosphatase genes in gastric and colon carcinomas with microsatellite instability
Sang Yong Song et al.
APMIS (2010)
MicroRNA Regulation of Cancer Stem Cells and Therapeutic Implications
Jeffrey T. DeSano et al.
AAPS JOURNAL (2009)
EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
Taro Yamashita et al.
GASTROENTEROLOGY (2009)
Common variants at five new loci associated with early-onset inflammatory bowel disease
Marcin Imielinski et al.
NATURE GENETICS (2009)
Significance of CD90+ cancer stem cells in human liver cancer
Zhen Fan Yang et al.
CANCER CELL (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway
S. Ma et al.
ONCOGENE (2008)
分享论文
